Literature DB >> 27141813

Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.

V Papaevangelou1, Z Alexopoulou2, C Hadjichristodoulou3, G Kourlamba4, A Katsioulis3, K Theodoridou2, V Spoulou2, M Theodoridou2.   

Abstract

Hepatitis A vaccine was introduced in the Greek National Immunization Program in 2008. To estimate possible impact of the universal vaccination implementation, time trends of hospitalizations for hepatitis A at the Infectious Diseases Unit of a Tertiary Pediatric Hospital in Athens during 1999-2013 were analyzed. Hepatitis A hospitalizations were recorded from the discharge database and were expressed as frequencies and rate of annual departmental hospitalizations. Time series analysis (ARIMA) was used to explore trends and the impact of the vaccination. Moreover, changes in patient age, population group distribution and the duration of hospitalization were also examined. Hepatitis A hospitalizations rate significantly decreased between pre-vaccination (1999-2008) and post-vaccination (2009-2013) era from 50.5 to 20.8/1000 hospitalizations (p = 0.005). A 3-year periodicity and a trend of reduction on hepatitis A hospitalizations rates across years were noted. Roma children had significant higher rates of hepatitis A hospitalization, followed by immigrant children. Importantly, possibly due to preceding vaccine availability with considerable uptake in private market and unvaccinated group/pockets of children (Roma), overall vaccination effect was less apparent when compared to data from other countries that implemented universal vaccination. No significant change in patient age, population group distribution, or duration of hospitalization was observed. High risk groups such as Roma children should be targeted for vaccination to reduce future outbreaks.

Entities:  

Keywords:  Roma; hepatitis A; hospitalization; time trends; universal vaccination

Mesh:

Substances:

Year:  2016        PMID: 27141813      PMCID: PMC4964822          DOI: 10.1080/21645515.2016.1151589

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction.

Authors:  Maria Theodoridou; Ioanna Laina; Christos Hadjichristodoulou; Vassiliki Syriopoulou
Journal:  Eur J Pediatr       Date:  2006-02-01       Impact factor: 3.183

2.  Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.

Authors:  Ana Martínez; Sonia Broner; Nuria Torner; Pere Godoy; Joan Batalla; Josep Alvarez; Irene Barrabeig; Neus Camps; Gloria Carmona; Sofía Minguell; Rosa Sala; Joan Caylà; Angela Domínguez
Journal:  Hum Vaccin       Date:  2011-01-01

3.  The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012.

Authors:  H Levine; E Kopel; E Anis; N Givon-Lavi; R Dagan
Journal:  Euro Surveill       Date:  2015-02-19

4.  Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?

Authors:  Domenico Martinelli; Isabella Bitetto; Silvio Tafuri; Pietro L Lopalco; Rosa Maria Mininni; Rosa Prato
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

5.  Measles outbreak in Andalusia, Spain, January to August 2011.

Authors:  Jm Mayoral Cortes; E Perez Morilla; V Gallardo Garcia; Jm Navarro Mari; M Perez Ruiz; R Hermosilla; J Diaz-Borrego; E Rodriguez Romero; J Ruiz Fernandez
Journal:  Euro Surveill       Date:  2012-10-18

6.  Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.

Authors:  Tara M Vogt; Matthew E Wise; Beth P Bell; Lyn Finelli
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

7.  Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.

Authors:  A Michos; A Terzidis; V Kalampoki; K Pantelakis; Th Spanos; E Th Petridou
Journal:  J Med Virol       Date:  2008-05       Impact factor: 2.327

8.  Surveillance for acute viral hepatitis - United States, 2007.

Authors:  Danni Daniels; Scott Grytdal; Annemarie Wasley
Journal:  MMWR Surveill Summ       Date:  2009-05-22

9.  Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks.

Authors:  Kassiani Mellou; Theologia Sideroglou; Vassiliki Papaevangelou; Anna Katsiaflaka; Nikolaos Bitsolas; Eleni Verykouki; Eleni Triantafillou; Agoritsa Baka; Theano Georgakopoulou; Christos Hadjichristodoulou
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

10.  Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy.

Authors:  Pietro Luigi Lopalco; Rosa Prato; Maria Chironna; Cinzia Germinario; Michele Quarto
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more
  4 in total

1.  A cross-sectional vaccination coverage study in preschool children attending nurseries-kindergartens: Implications on economic crisis effect.

Authors:  Theano Georgakopoulou; Damianos Menegas; Antonis Katsioulis; Maria Theodoridou; Jenny Kremastinou; Christos Hadjichristodoulou
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

Review 2.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

Review 3.  Hepatotropic viruses: Is Roma population at risk?

Authors:  Anna Mrzljak; Lucija Bajkovec; Tatjana Vilibic-Cavlek
Journal:  World J Gastroenterol       Date:  2021-01-14       Impact factor: 5.742

Review 4.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.